Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) |
Systemic Lupus Erythematosus | Phase3 | Argentina Australia Chile Colombia France Germany India Italy Malaysia Mexico Romania South Korea Taiwan United Kingdom United States View all |
NCT05624749 |
A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia |
HR+HER2- Advanced Breast Cancer | Russia | NCT06148506 | |
Dabrafenib and/or Trametinib Rollover Study |
Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers, High Grade Glioma | Phase4 | Spain United States |
NCT03340506 |
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease |
Sickle Cell Disease | Phase1, Phase2 | United States | NCT06546670 |
A Post Marketing Surveillance on Piqray in Korea |
Breast Cancer | South Korea | NCT05293470 | |
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN |
IC-MPGN | Phase3 | Argentina Brazil Canada France Germany Greece India Israel Italy Japan Netherlands Poland Slovakia South Korea Spain Switzerland Taiwan Turkey (Türkiye) United Kingdom United States Vietnam View all |
NCT05755386 |
A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission |
Non-radiographic Axial Spondyloarthritis | Phase4 | Belgium Brazil Colombia Czechia France Germany Hungary Israel Italy Malaysia Mexico Netherlands Philippines Poland Romania Thailand Turkey (Türkiye) Vietnam View all |
NCT05622708 |
The Belgian REAL (BE.REAL) Registry |
Atherosclerotic Cardiovascular Disease | Belgium | NCT05726838 | |
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) |
Atypical Hemolytic Uremic Syndrome | Phase3 | China France Germany Italy Japan Spain Turkey (Türkiye) United Kingdom View all |
NCT05935215 |
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. |
Lymphatic Malformations | Phase2, Phase3 | Australia Belgium France Germany Italy Netherlands Spain United States View all |
NCT05948943 |